Introduction
Throughout the history of the world, the ones who had confronted the bitterest face of poverty and war had always been the women. As known poverty and war affects human health either directly or indirectly, the effects of this condition on health and status of women in the society should not be ignored. This study intends to cast light on the effects of war and poverty on the reproductive health of women. For this purpose, the face of war affecting the women, the problem of immigration, inequalities in distribution of income based on gender and the effects of all these on the reproductive health of women will be addressed.
War and Women's Health
Famine, synonymous with war and poverty, is clearer for women; war means deep disadvantages such as full destruction, loss of future and uncertainty for women. Wars are conflicts that destroy families, societies and cultures that negatively affect the health of community and cause violation of human rights. According to the data of World Health Organization (WHO) and World Bank, in 2002 wars had been among the first ten reasons which killed the most and caused disabilities. Civil losses are at the rate of 90% within all losses (1) . War has many negative effects on human health. One of these is its effect of shortening the average human life. According to the data of WHO, the average human life is 68.1 years for males and 72.7 years for females. It is being thought that severe military conflicts in Africa shorten the expected lifetime for more than 2 years. In general, WHO had calculated that 269 thousand people had died in 1999 due to the effect of wars and that loss of 8.44 million healthy years of life had occurred (2, 3) . Wars negatively affect the provision of health services. Health institutions such as hospitals, laboratories and health centers are direct targets of war. Moreover, the wars cause the migration of qualified health employees, and thus the health services hitches. Assessments made indicate that the effect of destruction in the infrastructure of health continues for 5-10 years even after the finalization of conflicts (3) . Due to resource requirements in the restructuring investments after war, the share allocated to health has decreased (1).
Mortalities and Morbidities
The ones who are most affected from wars are women and children. While deaths depending on direct violence affect the male population, the indirect deaths kill children, women and elders more. In Iraq between 1990-1994, infant deaths had shown this reality in its more bare form with an increase of 600% (4). The war taking five years increases the child deaths under age of 5 by 13%. Also 47% of all the refugees in the world and 50% of asylum seekers and displaced people are women and girls and 44% refugees and asylum seekers are children under the age of 18 (5) . As the result of wars and armed conflicts, women are
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Given the prevalence of sexual problems during menopause, women's interest in taking complementary medicine to reduce the symptoms of menopause (13) , use of herbal medicines with less side effects and accelerating the treatment procedure, positive impact of Ginkgo biloba in some studies, studying the plant in different doses and population (18, 19) and the lack of research about the effects of aromatherapy on sexual function, this study aimed to evaluate the combined effect of herbal therapy by Ginkgo biloba and aromatherapy on sexual function in postmenopausal women.
Materials and Methods
This study was a double blind randomized controlled clinical trial conducted from August 2014 to March 2016 on 180 postmenopausal women referred to health centers in Ardabil, Iran to determine the combined effect of Ginkgo biloba tablet and aromatherapy inhaler pill on sexual function in postmenopausal women. The number of samples in each intervention and placebo groups was 60 at random allocation using a computergenerated randomization scheme with blocks 3 and 6 and allocation ratio of 1: 1: 1. Eligibility criteria were: women with natural menopause, not taking any effective drug on sexual response, lack of mental health problems or known systemic diseases affecting sexual function, no loss of smell declaring by the individual and other nasal disorders, lack of digestive disorders such as nausea, vomiting, abdominal pain and stomach cramps. After explaining the purpose of the study and signing an informed consent form by the eligible women, demographic characteristics questionnaire and Female Sexual Function Index (FSFI) were completed. This questionnaire was also completed once again by the participants after intervention. The validity and reliability of the questionnaire were confirmed by Mohammadi et al in Tehran in 53 women with sensitivity of 83% and specificity of 82% (26) .
Sealed opaque envelope coded from 1 to 180 were used to keep the allocation concealment and drugs including 2 bottles of solution and 126 tablets that were put in the envelope on the basis of random allocation sequence by an uninvolved individual in the research. Enrolling the people to study and delivering packets from 1 to 180 respectively were done by the researchers themselves. The first intervention group took 40 mg Ginkgo biloba tablet and 2-3 drops of aroma of placebo 3 times a day for 6 weeks, the second intervention group took 2-3 drops of aroma solution (combination of lavender, fennel, geranium and rose) and 40 mg of Ginkgo biloba placebo 3 times a day for 6 weeks and placebo group took placebo tablets 40 mg and placebo aroma simultaneously. Aroma solution was used on the skin of forearm. The researcher contacted the participants to be ensured if they took their drugs. They were also given check lists for checking the use of the drugs by the end of the day. In this study Ginkgo biloba placebo tablets and aroma solution placebo were the same as original drug in shape, size and color, so the researcher and participants were all blind. However, the aroma solution placebo was without fragrance which was considered as the study limitation.
Descriptive statistics such as mean and standard deviation, frequency, percentage and inferred statistics were used after collecting data from all subjects. So that one-way analysis of variance (ANOVA) was used to compare total score of sexual function and its subdomains among three groups before the intervention and analysis of covariance (ANCOVA) was used to compare the overall scores of sexual function and its sub-domains between the groups after the intervention with modulating basic variables and potential confounder (score of sexual function before intervention, education, income, family size, etc). Paired t test was used for within group comparison. Chi-square tests, one-way ANOVA and chisquare with trend were used to compare the demographic characteristics. The data were analyzed using SPSS 21 at the significant level of 0.05. The analysis was done based on intention-to-treat.
The sample size was calculated regarding to total score of sexual function in study by Amiri (19) using Pukak formula to compare differences between groups considering the increase in the average sexual function score of 30% with respect to the power of 85% and confidence of 95% and regarding the possibility of 20% loss of samples, 60 was considered for each group. The overall mean (SD) scores of sexual function before and after the intervention were 29.8 (16.2) and 38.7 (15.9), respectively.
Results
Participants were enrolled from July 2014 to March 2015 and were followed for 6 weeks. Three patients in the placebo group, 3 in aromatherapy and 1 in Ginkgo biloba withdrew during the study. As a result 57 in aroma, 59 in Ginkgo biloba and 57 in placebo group were analyzed ( Figure 1 ). The majority of the participants in Ginkgo biloba (61.7%), aromatherapy (51.7%) and placebo group (65.0%) were in age range of 51-55, 51-55 and 50-55 years, respectively. The education level of majority of women was elementary in all 3 groups: Ginkgo biloba (43.3%), aroma (66.7%) and placebo (45%). The majority of participants' spouses were employees: Ginkgo biloba (66.7%), aroma (91.2%) and placebo (78.3%). The education level of majority of participants' spouses in Ginkgo biloba (33.3%), and aroma (66.7%) was elementary and in the placebo (28.3%) was high school education. The highest percentage of women in Ginkgo biloba (41.4%) and placebo (55.9%) reported their monthly income for living costs as "fairly adequate. " However, it was "inadequate" in aroma group (55.2%). The mean (SD) of body mass index (BMI) in Ginkgo biloba, aroma and placebo groups were 26.2 (4.05%), 29.8 (5.6%) and 27.5 (3.5%), respectively. The mean (SD) number of children in Ginkgo biloba, aroma and placebo groups were 4.1 (81.8%), 5.1 (2.1%) and 3.6 (1.7%), respectively. The mean (SD) number of family members in Ginkgo biloba, aroma and placebo groups were 2.9 (1.3%), 3.8 (1.6%) and 3.7 (1.2%), respectively. There was statistically significant difference among the three groups in terms of age, number of children, family size, spouse's job, spouse's education level and income adequacy (P < 0.05; Table 1 ).
The mean (SD) total scores of sexual function, libido, sexual arousal, vaginal lubrication, orgasms, pain during intercourse and sexual satisfaction in the three groups of aroma, Ginkgo biloba and placebo before the intervention were respectively as follows: total sexual function: 18.4 (5.4%), 17.5 (6.8%), 15.8 (5.7%); libido: 2.9(2.1%), 2.7 (2.1%), 2.4 (1.1%); sexual arousal: 2.7 (1.1%), 2.4 (3.1%), 2.02 (1.1%); vaginal lubrication: 3.3 (0.9%), 3.0 (4.1%), 2.4 (1.2%); orgasm: 3.1(1.1%), 2.8 (4.1%), 2.8 (1.8%); pain during intercourse: 3.5 (1.5%), 1.7 (3.8%), 2.9 (1.7%) and sexual satisfaction: 2.9 (1.4%), 2.7 (1.6%), 3.4 (1.6%). The results of one way ANOVA showed a significant difference among the three groups before the intervention in terms of the total score and all other sub-domains of sexual function except orgasm and libido sub-domains (Table 2) .
After intervention, the mean (SD) total score of sexual function in aroma, Ginkgo biloba and placebo groups were 22.9 (0.4%), 21.6 (4.6%) and 17.2 (4.2%), respectively. In terms of the dimensions of sexual function scores among samples, the mean (SD) total scores of libido, sexual arousal, vaginal lubrication, orgasms, sexual satisfaction and pain during intercourse in the three groups of aroma, Ginkgo biloba and placebo after the intervention were respectively as follows: libido: 4.0 (1.1%), 3.6(1.0%), 2.7 (1.1%); sexual arousal: 3.8 (0.9%), 3.6 (1.1%), 2.4 (0.9%); vaginal lubrication: 3.7 (0.4%), 3.5 (0.7%), 2.6 (0.9%); orgasms: 3.9 (0.6%), 3.5 (0.9%), 2.7 (1.1%); sexual satisfaction: 4.3 (1.2%), 3.9 (1.3%), 3.5 (1.6%), and pain during intercourse: 3.2 (0.7%), 3.4 (1.1%), 3.2 (0.7%).
The results of ANCOVA test with the control of the effect of baseline sexual function score and the confounding variables showed significant differences among the three groups after the intervention in terms of the total scores and all sub-domains of sexual function except sexual satisfaction and pain during intercourse (P < 0.003; Table 2 ).
The results of ANOVA test with the control of the effect of sexual function score before the intervention and the confounder variables showed statistically significant differences between total score and all sub-domains of sexual function other than pain during intercourse among the study subjects in Ginkgo biloba with placebo (adjusted mean difference 3.89; 95% CI: 2.25 to 25.5), and aromatherapy with placebo (adjusted mean difference 4.78; 95% CI 3.26 to 6.48), (P < 0.001; Tables 3 and 4) .
Headache was reported as the common side effect in the Ginkgo biloba group (7% of the samples). Among 7% of the subjects, forearm itching was the most common side effect of aromatherapy (Table 5 ). 38.9% percent of subjects were satisfied and 33.9% were very satisfied by taking Ginkgo biloba. 50.9% of the subjects were very satisfied and 31.6% satisfied with aromatherapy because of their sexual function improvement.
Discussion
The results of this study showed that there was significant Lost to follow-up (n=3) statistical difference among the mean total scores related to sexual function, sexual arousal, vaginal lubrication, orgasm and sexual satisfaction between the placebo group and the other two groups of Ginkgo biloba and aromatherapy after intervention by controlling baseline values and confounder variables (P < 0.003). While Oh et al were trying to determine the estrogenic activity of Ginkgo biloba, they found that the main compounds of Ginkgo biloba had the poor estrogenic activity, which could be used as hormone replacement therapy instead of estrogens (16) . In their study, Cohen and Bartlik showed that a daily intake of 120 to 240 mg Ginkgo biloba among men and women under age of 65 could lead to sexual function improvement (27 (19) . The results of our study are consistent with the cited studies.
Although some studies showed a positive effect of Ginkgo biloba on sexual activity, some others did not report any improvement in sexual activity. In a clinical trial study conducted by Wheatley in the United Kingdom to determine the effect of Ginkgo biloba on sexual function in men and women aged at 18-65 yrs under depression treatment, taking 240 mg Ginkgo biloba extract caused no change in sexual activity improvement (29) . Failure to consist with our study could be due to the differences in health status of the subjects because their samples were men and women treated for depression, while our samples were only healthy postmenopausal women. Meston et al in the United States reported no improvement in sexual satisfaction of women taking 300 mg Ginkgo biloba (18) . Lack of consistent with the present study could be due to racial-geographical difference among study samples. The mechanism of action of Ginkgo biloba is because of phytoestrogens. Phytoestrogens act as estrogen agonists and may cause effects similar to estrogen (30) . A number of aromatic herbal essences like fennel, angelica, sage and bergamot, lavender and geranium containing phytoestrogens in aroma can reduce climacteric symptoms such as hot flashes, sexual dysfunction and depression by activating neurons in the olfactory center that affect human emotions by releasing different neurotransmitters (endorphins, noradrenalin and serotonin) (22) (23) (24) . Geranium extract reduces menopausal symptoms and depression (25) . Aroma therapy reduces climacteric symptoms such as hot flashes, depression and pain during intercourse (25, 31) . In a study by Malakoti et al on the effect of aromatherapy on sexual function of lactating women, improvement was observed in lactating women 40 days after the use of aroma (32) . No study was found to show the effects of aromatherapy only on sexual function in postmenopausal women in order to be compared with this study.
In study by Hur et al on 25 postmenopausal women in Korea showed that massage with aromatic oils of lavender, Geranium, jasmine, almond and evening primrose oil reduces climacteric symptoms such as depression, hot flashes and pain during intercourse. The participants had used aromatherapy massage 30 minutes a week for 8 weeks (31) . In a study by Marzouk et al on nursing students 
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showed that aromatherapy decreased dysmenorrhea (33) . In a study by Darsareh et al on the impact of aromatherapy massage with geranium extract on menopausal symptoms, reduced menopausal symptoms and depression (25) which is consistent with this study. Essential oils in aromatherapy usually affect through 2 different ways (34): 1) through sense of smell, so that by inhaling the odor molecules, olfactory receptors send impulses to the olfactory area of brain. This area is closely related with other controlling systems such as memory, emotions, hormones, sexual feelings and heart rate. Impulses trigger the release of hormones substances that are capable of stimulating, incubation, calming or creating euphoria and lead to physical and mental changes. And 2) by skin absorption: volatile oils in the skin are very penetrating and can pass through the blood capillaries and reach the derma to exert their effects. The analgesic effects of essential oils are applied through four mechanisms including (30) oil chemical complex effects on memory and behavioral areas (31), the effect of these extracts on brain dopamine, serotonin and nor epinephrine (33) , stimulate the endocrine opioid system (25) and impact on touch interaction with sensory fibers of the skin. Since questionnaires were filled by samples themselves they may have got the wrong impression and not answered correctly. In addition, as a number of participants complained from drugs' side effects such as headaches and gastric pain, it could be recognized as one of the limitations of the study. Another weakness of the study was the impossibility of providing aroma placebo with same odor. Meanwhile double-blindness in terms of the drugs and analysis were the strengths of the study.
Conclusion
Regarding the findings indicating the positive impact of combination of aromatherapy inhaler in improving sexual performance without any side effects in postmenopausal women, it is recommended that midwives could suggest the use of aroma to resolve sexual dysfunction in postmenopausal women. Aromatherapy in all subdomains of sexual function other than "pain during intercourse" was effective in improving sexual function in postmenopausal women. Results revealed that Ginkgo biloba tablet also had a positive effect on improvement of sexual function, however, future study with higher doses of drugs as well as long follow-up are needed to see its effect. Other studies are recommended to compare aroma solution and Ginkgo biloba with other effective herbal compounds in the treatment of sexual dysfunction in postmenopausal women.
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